Teladoc Health, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Charles Divita
- Full Time Employees
- 5,600
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 2 Manhattanville Road New York NY United States of America 10577
- IPO Date
- Jun 30, 2015
- CIK
- 0001477449
- Website
- teladochealth.com
- Similar Companies
- Business
- Teladoc Health, Inc. delivers a broad spectrum of virtual healthcare solutions across the United States and internationally. The company offers a comprehensive portfolio spanning from routine, acute, and chronic medical challenges to intricate health conditions, encompassing areas such as diabetes management, hypertension, renal issues, oncology, heart failure, and diverse mental well-being services. Its offerings include primary care and specialized telehealth consultations, sophisticated chronic disease management programs, expert medical second opinions, dedicated mental health support, and robust platform services. Serving a wide client base, Teladoc Health partners with employers, health plans, hospital networks, and financial services firms, alongside individual members. The company markets its products and services under prominent brands like Teladoc, Livongo, and BetterHelp. Established in 2002, the firm is headquartered in Purchase, New York. Recent strategic initiatives include the acquisition of Uplift in April 2025 to expand mental health offerings with in-network health plans, and the launch of a next-generation Cardiometabolic Health Program.
Teladoc Health (TDOC) Securities Investigation Notice - Levi & Korsinsky
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
Securities Fraud Investigation Into Teladoc Health Inc. (TDOC) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Teladoc Health Inc. (TDOC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Securities Fraud Investigation Into Teladoc Health Inc. (TDOC) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Teladoc Health (TDOC)
TDOC Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Teladoc Health (TDOC)
TDOC Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Teladoc Health (TDOC)
Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors
Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors
Are Investors Undervaluing Teladoc Health (TDOC) Right Now?
TDOC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Teladoc Health
Teladoc Health Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Teladoc Health (TDOC)
Teladoc Health Q2 Earnings Beat Estimates on Integrated Care Strength
Teladoc Stock Plummets on Revenue Miss, Lowered Outlook
Why Teladoc Health Stock Is Dropping Thursday Following Soft Q3 Outlook
Teladoc Health Q2 Earnings Call Highlights
Teladoc tumbles on revenue forecast cut as BetterHelp demand shifts hurt
Teladoc Health, Inc. (TDOC) Q2 2026 Earnings Call Transcript